Outcomes and Return-to-Sport Rates for Elite Athletes With Femoral Retroversion Undergoing Hip Arthroscopy: A Propensity-Matched Analysis With Minimum 2-Year Follow-up
Authors
Owens JS, Jimenez AE, Lee MS, Maldonado DR, Lall AC, Domb BG
Journal
Orthop J Sports Med, June 2022
Background
Femoral retroversion in elite athletes undergoing hip arthroscopy has not been well studied. This study evaluates the outcomes and return-to-sport (RTS) rates for these athletes.
Methods
- The study reviewed outcomes for elite athletes with femoral retroversion undergoing hip arthroscopy for femoroacetabular impingement syndrome (FAIS) between 2010 and 2018.
- Athletes with normal femoral version were used as a propensity-matched control group.
- Preoperative and 2-year postoperative PROs, along with RTS rates, were analyzed.
Key Findings
- Athletes with femoral retroversion demonstrated significant improvements in PROs and achieved high rates of minimal clinically important difference (MCID) and patient acceptable symptom state (PASS) for the Hip Outcome Score-Sport Specific Subscale (HOS-SSS).
- RTS rate for the retroversion group was 83.3%, which was comparable to the control group.
Conclusions
Elite athletes with femoral retroversion undergoing hip arthroscopy achieve favorable outcomes, similar to athletes with normal femoral version. High rates of RTS were observed, making hip arthroscopy an effective treatment for these athletes.
What Does This Mean For Patients
Elite athletes with femoral retroversion can expect favorable outcomes and a high likelihood of returning to their sport after hip arthroscopy, similar to athletes without retroversion.